Sun Pharma has engaged a European bank as an advisor to structure a comprehensive financial proposal that may be presented to ...

Is Back on Investors’ Radar Pfizer (PFE) is attracting fresh attention after a period of mixed share performance, with the ...

Shionogi has agreed to raise its stake in London-based drugmaker ViiV Healthcare by acquiring additional shares for $2.125 ...

Invesco Equity And Income Fund's Q4 2025 report highlights strategic shifts toward AI-driven electronics and medical diagnostics. Read the full analysis now.

Invesco Equity and Income Fund lagged its benchmark in Q4 2025 as IT and fixed income weighed. See new holdings and full ...

Pfizer is one of the world's largest pharmaceutical companies. Even after losing more than half of its value, it still has a ...

MoneyShow presents top investment ideas for 2026 from leading advisors. Part 7 includes Pfizer, Philip Morris International, ...

Let's discuss how the drugs in these two non-oncology segments are expected to have performed in the third quarter. In ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, ...

CGO offers a globally diversified, hybrid portfolio with a current yield of 8.03%. See why CGO is a Hodd for existing ...

Unfortunately, there is no easy button in real life. However, if you're an income investor, a strategy exists that comes ...

Dividend-paying stocks can really boost an individual investor's portfolio. If you're in the market for some no-brainer ...